Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mid-Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06454201
What this trial is testing

Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer

Who this might be right for
Natural Orifice Specimen Extraction SurgeryMiddle Rectal CancerRobotic+1 more
Nanchang University 150
Not applicableUnknownNCT04751149
What this trial is testing

Incidence of Acute Urine Retention: Randomized Clinical Trial Comparing Early, Mid or Late Urinary Catheter Removal in Patients With Rectal Resection

Who this might be right for
Rectal CancerRetention, UrinaryUrinary Tract Infections+2 more
Hospital Donostia 143
Testing effectiveness (Phase 2)Study completedNCT06333769
What this trial is testing

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Who this might be right for
Mid-low Rectal Cancer
Fujian Cancer Hospital 38
Not applicableUnknownNCT02395224
What this trial is testing

A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway

Who this might be right for
Neoplasms, ColorectalNeoplasm Metastasis
Norwegian University of Science and Technology 354
Not applicableStudy completedNCT03574493
What this trial is testing

Rectal Surgery Evaluation Trial (RESET)

Who this might be right for
Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 1,098
Not applicableLooking for participantsNCT06236633
What this trial is testing

Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum

Who this might be right for
Cancer, Rectal
Centre Hospitalier Universitaire de Nīmes 30
Not applicableUnknownNCT00819559
What this trial is testing

Preoperative Chemoradiotheray for Rectal Cancer

Who this might be right for
Rectal Neoplasm
Korean Rectal Cancer Study Group 1,160
Post-approval studies (Phase 4)Looking for participantsNCT07209787
What this trial is testing

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Who this might be right for
Rectal Cancer
Beijing Chao Yang Hospital 966
Testing effectiveness (Phase 2)Looking for participantsNCT07458529
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant TherapyImmunotherapy+3 more
Seventh Medical Center of PLA General Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06507371
What this trial is testing

Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer

Who this might be right for
Rectal Cancer
Sir Run Run Shaw Hospital 170
Not applicableNot Yet RecruitingNCT06414122
What this trial is testing

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

Who this might be right for
Oesophageal CancerGastric CancerDuodenal Cancer+1 more
University of Cologne 88
Not applicableUnknownNCT02165800
What this trial is testing

Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients

Who this might be right for
Rectum Neoplasms
Third Affiliated Hospital, Sun Yat-Sen University 667
Testing effectiveness (Phase 2)Study completedNCT06108596
What this trial is testing

Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail

Who this might be right for
Locally Advanced Rectal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 33
Not applicableUnknownNCT02817126
What this trial is testing

Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer

Who this might be right for
Rectal Carcinoma
Fudan University 1,240
Testing effectiveness (Phase 2)UnknownNCT05845268
What this trial is testing

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 102
Large-scale testing (Phase 3)UnknownNCT03242187
What this trial is testing

Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer

Who this might be right for
Rectal Cancer
Mansoura University 30
Not applicableLooking for participantsNCT07467434
What this trial is testing

FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases

Who this might be right for
Rectal CancerSynchronous Liver MetastasesAntineoplastic Combined Chemotherapy Protocols+1 more
Assistance Publique - Hôpitaux de Paris 550
Large-scale testing (Phase 3)Looking for participantsNCT03051464
What this trial is testing

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

Who this might be right for
Stage II Rectal CancerOrgan PreservationNon-operative Treatment+2 more
Sir Mortimer B. Davis - Jewish General Hospital 131
Large-scale testing (Phase 3)UnknownNCT02736942
What this trial is testing

COLOR III Trial: Transanal vs Laparoscopic TME

Who this might be right for
Rectal CarcinomaSurgery
Amsterdam UMC, location VUmc 1,104
Large-scale testing (Phase 3)Not Yet RecruitingNCT06443671
What this trial is testing

Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 132
Next Page